CN113025634A - Gene sequence containing sugar alcohol and ATP binding domain and expression and function verification method of gene sequence in yarrowia lipolytica - Google Patents

Gene sequence containing sugar alcohol and ATP binding domain and expression and function verification method of gene sequence in yarrowia lipolytica Download PDF

Info

Publication number
CN113025634A
CN113025634A CN202110247016.2A CN202110247016A CN113025634A CN 113025634 A CN113025634 A CN 113025634A CN 202110247016 A CN202110247016 A CN 202110247016A CN 113025634 A CN113025634 A CN 113025634A
Authority
CN
China
Prior art keywords
ala
gly
gene
sequence
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110247016.2A
Other languages
Chinese (zh)
Other versions
CN113025634B (en
Inventor
裴疆森
李红娇
周芸琪
金玮鋆
董建辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China National Research Institute of Food and Fermentation Industries
Original Assignee
China National Research Institute of Food and Fermentation Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China National Research Institute of Food and Fermentation Industries filed Critical China National Research Institute of Food and Fermentation Industries
Priority to CN202110247016.2A priority Critical patent/CN113025634B/en
Publication of CN113025634A publication Critical patent/CN113025634A/en
Application granted granted Critical
Publication of CN113025634B publication Critical patent/CN113025634B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/18Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a gene sequence containing a sugar alcohol and ATP binding domain and a construction method of a yarrowia lipolytica recombinant strain containing the sequence, belonging to the field of microbial genetic engineering. The nucleotide sequence of the gene is shown as SEQ ID NO.1, and after the gene is expressed in yarrowia lipolytica, the assimilation performance difference of the recombinant strain to carbohydrate such as erythritol, ribose and the like of a yeast strain is obvious, so that the gene is presumed to be a new gene with erythritol synthesis regulation and control capacity. The recombined yarrowia lipolytica strain also shows the assimilation capability of various sugar alcohols and some non-fermentable disaccharides in the mother liquor extracted from the erythritol fermentation liquor of the normal yarrowia lipolytica, and has practical application value for improving the substrate utilization capability of the yarrowia lipolytica and comprehensively utilizing waste liquor in the erythritol production process.

Description

Gene sequence containing sugar alcohol and ATP binding domain and expression and function verification method of gene sequence in yarrowia lipolytica
Technical Field
The invention belongs to the technical field of yeast genetic engineering and microorganisms, and particularly relates to a gene sequence containing a sugar alcohol and ATP binding domain, a recombinant strain construction method containing the sequence and a recombinant strain function verification method.
Background
Erythritol widely exists in microorganisms such as yeast, algae, mushrooms and the like in nature, belongs to a sugar alcohol natural sweetener, has extremely low heat, is difficult to absorb moisture, is stable at high temperature and has certain antioxidant activity, does not cause insulin level change in human metabolism, and does not cause great fluctuation of blood sugar after being eaten. Bacteria in the oral cavity generally do not utilize such sweeteners and do not cause dental caries on long-term consumption. Therefore, the erythritol can be used as a functional sugar substitute to be added into non-calorie or low-calorie foods, and is more suitable for patients with obesity and diabetes when being applied to medical products. The common microbial fermentation method for producing erythritol mainly uses starchy raw materials of wheat, corn and the like to be degraded into glucose by enzyme, and then uses hypertonic resistant yeast such as Pichia (Pichia) Yarrowia genus (Yarrowia) Candida genus (Candida) Torulopsis genus (A)Torulopsis) Trigonopsis genus (A)Trigonopsis) The erythritol is obtained by fermentation with glucose as a substrate and subsequent steps of filtering, separating and purifying and the like as a production strain, the average yield is about 50%, and industrial mass production is performed due to high production efficiency, mild reaction and low cost.
The yarrowia lipolytica mainly takes glucose and glycerol as fermentation substrates to synthesize erythritol. In an anabolic pathway taking glucose as a carbon source, through glycolysis, hexokinase catalyzes glucose to generate glucose-6-phosphate, glucose-6-phosphate dehydrogenase catalyzes glucose-6-phosphate to enter a pentose phosphate pathway to generate erythrose-4-phosphate, and erythritol is generated under the catalysis of erythrose-4-phosphate kinase and erythrose reductase. Host bacterium yarrowia lipolytica (Yarrowia lipolytica) Is a safe non-pathogenic strain, hasComplete the sequencing of the whole genome and mitochondria, complete gene operation means, can utilize cheap substrates and various carbon sources to secrete metabolites, can produce compounds with certain industrial value through a directional shunt metabolic pathway, gradually becomes a yeast expression system and is widely applied to food and medicine production.
Disclosure of Invention
The invention discloses a gene sequence containing a sugar alcohol and an ATP binding domain, which comprises the following steps:
the nucleotide sequence of the gene is shown in SEQ ID NO.1 and consists of 1831 nucleotides.
② the nucleotide sequence shown by SEQ ID NO.1 is substituted, added and deleted with one or more nucleotides to obtain the sequence of coding the same functional gene.
And the sequence of the coding same functional gene with homology of more than 75 percent with the sequence shown in SEQ ID NO. 1. The gene sequence of the present invention can be mutated by a known method such as point mutation by a person skilled in the art, and a nucleotide sequence having 75% or more identity to the nucleotide sequence provided by the present invention which has been artificially modified is derived from the gene sequence of the present invention and is equivalent to the sequence of the present invention as long as it has the same function as the protein encoded by the gene sequence.
"identity" refers to similarity to a nucleotide sequence of the present invention. "identity" includes nucleotide sequences having 75% or more homology with the sequence shown in SEQ ID No.1 of the present invention. Identity can be assessed by computer sequence alignment software or by the BLAST algorithm for sequence homology, and identity between two or more sequences is expressed as a percentage.
The amino acid sequence of the gene sequence expression protein is shown as SEQ ID NO.2 and consists of 603 amino acids. The protein with the same function obtained by substituting, deleting and adding no more than 10 amino acid residues to the amino acid sequence shown in SEQ ID No.2, or the protein with 75 percent or higher homology and the same function with the amino acid sequence shown in SEQ ID No.2 is derived from the amino acid sequence of the invention and is identical with the sequence of the invention.
The invention provides biological materials containing the gene sequence, including recombinant vectors and recombinant strains. In the present invention, the cloning Vector is a pMD18-T Vector-spx recombinant cloning Vector (FIG. 1) obtained by inserting a cloned target gene into a pMD18-T cloning Vector; the recombinant expression vector is pINA1269-spx recombinant expression vector obtained by inserting target gene spx into pINA1269 plasmid, specifically is a recombinant expression vector obtained by inserting target fragment shown by 1-1831 bit nucleotide from 5' end of SEQ ID No.1 into polyclonal enzyme cutting site (between Pml I and Kpn I enzyme cutting recognition site) of pINA1269 vector, and the promoter of the target gene in the expression vector is hp4d promoter carried on pINA1269 plasmid (figure 2); the recombinant strain is obtained by transforming a recombinant expression vector pINA1269-spx into a host yarrowia lipolytica yeast and screening and identifying.
The gene sequences of the invention are derived fromZygoascus hellenicusAn ORF sequence with sugar phosphorylation function obtained by yeast in whole genome sequencing analysis, named spx, is predicted by nucleic acid conserved domain alignment and structural domain (FIG. 3), and contains a sugar binding domain and an ATP binding domain, and is related to pentose or hexokinase gene families. The functional gene sequence of the invention has the effects that: compared with an unmodified parent strain, the difference of the recombinant strain for over-expressing the gene in the assimilation performance of erythritol, ribose and other carbohydrates is obvious, which shows that the gene is related to erythritol synthesis and pentose metabolic pathway, the gene is a new gene capable of regulating erythritol synthesis, and a new direction is provided for further modifying a sugar alcohol metabolic pathway, expanding a fermentation available carbon source and improving erythritol yield; in addition, the erythritol crystallization mother liquor contains unused glucose, uncrystallized erythritol, residual mannitol, ribitol, glycerol and other complex components, the viscosity of the mother liquor is reduced after the recombinant strain is fermented, the components of the mother liquor are changed, and a new scheme is provided for the treatment and comprehensive utilization of fermentation waste liquor.
Drawings
FIG. 1 is a schematic representation of the recombinant cloning Vector pMD18-T Vector-spx;
FIG. 2 is a schematic representation of the recombinant expression vector pINA 1269-spx;
FIG. 3 is a screenshot of an alignment of the conserved domain of the spx sequence;
FIG. 4 is a comparison graph of high performance liquid chromatography for reusing erythritol crystallization mother liquor by a recombinant yarrowia lipolytica strain overexpressing spx gene and a parent strain.
Detailed Description
The following examples are intended to illustrate the invention but are not intended to limit the scope of the invention.
Materials, reagents and the like used in examples are commercially available unless otherwise specified. In the examples, the symbol "%" is used in percent by mass unless otherwise specified.
Example 1: cloning of the Gene of interest
Extracting original strain by using Tiangen yeast genome extraction kitZygoascus hellenicusThe target fragment was amplified from the genomic DNA of yeast using the template and Primer Premier 5 designed specific primers. Wherein the forward primer for amplifying the target fragment is spx-F: 5' -AGCACGTGATGTCAGATTCAAACGGCCCTCTTTAT-3' carrying a Pml I cleavage site. The reverse primer is spx-R: 5' -CGGGTACCTTATACAAGCCGAGACTCCATCTG-3', carrying a Kpn I cleavage site. The PCR reaction system is 0.5 mu L TaKaRaTaqPolymerase (5U/. mu.L), 5.0. mu.L 10 XPCR Buffer (Mg)2+ Plus), 4.0. mu.L dNTP mix (2.5mM each), 1.0. mu.L Forward Primer (20. mu.M), 1.0. mu.L Reverse Primer (20. mu.M), 2.5ng template DNA, up to 50. mu.L sterile distilled water. The PCR reaction program is: 3min at 94 ℃; 94 ℃ 30sec, 56 ℃ 30sec, 72 ℃ 1min45s, 30 cycles; 7min at 72 ℃; forever at 4 ℃.
Example 2: construction of pMD18-T Vector-spx recombinant cloning Vector
Detecting PCR product by agarose gel electrophoresis, and recovering target fragment by OMEGA gel recovery kit. The recovered product was ligated into pMD18-T Vector Cloning Kit (TaKaRa), reaction system: mu.L of pMD18-T Vector, 4. mu.L of recovered product, 5. mu.L of Solution I, up to 10. mu.L of ddH2O, mix well and attach overnight at 16 ℃. The ligation mixture was transformed into DH 5. alpha. competent cells and the ligation mixture was added to 150. mu.L of DH 5. alpha. competent EP tube in ice bath for 30min, at 42 ℃ for 90s and in ice bath for 5 min. Adding intomu.L of LB liquid medium (total volume 1 mL), resuscitated at 37 ℃ and 100r/min for 1 h. Centrifuging the resuscitating bacterial liquid for 2min at 5000r/min, discarding the supernatant, leaving 100 mu L of suspended bacteria, coating the resuscitating bacterial liquid on an LB (lysogeny broth) plate containing Amp resistance, carrying out inversion culture at 37 ℃ overnight, selecting a single colony on a transformation plate, extracting plasmid DNA (deoxyribonucleic acid) after the LB liquid culture, carrying out double enzyme digestion identification, verifying the size of an enzyme digestion fragment by agarose gel electrophoresis, and sending the recombinant clone T vector successfully constructed by the verification to Shanghai biological engineering company Limited for sequencing.
Example 3: construction of pINA1269-spx recombinant expression vector
Extracting pINA1269 plasmid DNA by using an OMEGA plasmid miniprep kit, carrying out double digestion by Pml I and Kpn I, carrying out agarose gel electrophoresis, and then recovering. Similarly, the target fragment is obtained and recovered by Pml I and Kpn I double enzyme digestion construction success recombination clone T carrier, the purified carrier and the target fragment are connected by TaKaRa T4 DNA ligase, the connection system is: mu. L T4 ligase, 2. mu.L 10 XBuffer, 10. mu.L recovered spx target fragment, 4. mu.L recovered pINA1269 vector fragment (molar ratio of target fragment to vector fragment 7: 1), up to 20. mu.L ddH2And O, transforming to DH5 alpha competence, coating on an LB plate containing Amp resistance, culturing overnight at 37 ℃, selecting a transformant, carrying out colony PCR verification by using primers spx-F and spx-R used in amplification of an integration target fragment, transferring the verified recombinant into an LB liquid culture medium, extracting plasmid DNA after culture, carrying out double digestion identification, and sending to Shanghai biological engineering corporation Limited for sequencing after double verification to obtain a successfully constructed pINA1269-spx expression vector.
Example 4: recombinant expression vector transformation of yarrowia lipolytica
Preparing host strain yeast competence, streaking yarrowia lipolytica strain on YPD solid culture medium, culturing at 30 deg.C for 2 days, selecting single colony, shake culturing at 30 deg.C and 220r/min in YPD liquid culture medium for 18h, and inoculating to 50mLYPD culture medium (initial OD)6000.1-0.15), shaking and culturing at 30 deg.C for 4 hr (to OD)6000.4-0.6), subpackaging the bacterial liquid at 25 ℃, centrifuging at 4000r/min for 5min, discarding the supernatant, collecting the thalli, and resuspending the thalli by using a 100mM LiAc solution to obtain the yeast competent cells.
The recombinant expression vector pINA1269-spx is treated by a restriction enzyme Not1 in a linear mode by adopting a lithium acetate chemical transformation method and is introduced into host bacteria yarrowia lipolytica competent cells, and the transformation system is as follows: 100ng of enzyme digestion purification vector, 600 mu L of 50% PEG4000, 10 mu L of inactivated salmon sperm DNA, 100 mu L of yeast competed, incubation is carried out for 30min at 30 ℃ after gentle mixing, heat shock is carried out for 15min at 42 ℃ after gentle inversion and uniform mixing is carried out every 5-10min, the mixed liquor of the processed yeast transformation system is centrifuged, supernatant is discarded, 100 mu L of culture medium is used for suspension coating on YNB screening culture medium (2% glucose, 0.67% non-amino yeast nitrogen source, 2% agar, pH5.5), inverted culture is carried out for 3-5 days at 28 ℃, yeast transformants growing on the screening culture medium are picked and inoculated on liquid culture medium, bacterial liquid is collected to extract yeast genome, primers spx-F and spx-R during amplification of integration target fragments are used as templates for PCR verification, and the transformants which are verified to be positive are the successful lipolysis yarrowia yeast recombinant strain.
Example 5: experiment for utilizing and transforming different carbon sources by recombinant strain
The host strain and the recombinant strain are respectively inoculated into 2.5mL of liquid culture medium (0.3% yeast extract powder, 0.5% peptone and 5% glucose), and shake-cultured at 28 ℃ for 24h to obtain seed liquid. Then inoculating the seed liquid into 8 fermentation culture media with different carbon sources, namely 1% xylitol, 1% sorbitol, 1% glycerol, 1% erythritol, 1% xylose, 1% ribose, 1% arabinose and 1% mannitol in an inoculation amount of 10%, wherein the other components of the fermentation culture media are the same as: 10 percent of glucose, 0.5 percent of yeast extract powder, 0.5 percent of triammonium citrate, 0.025 percent of magnesium sulfate, 0.025 percent of monopotassium phosphate, and shaking culture at 28 ℃ and 280 r/min for 72 hours to obtain fermentation liquor.
The fermentation broth is diluted and filtered, and the sugar and sugar alcohol contents are detected by an HPLC method. HPLC chromatographic conditions, chromatograph: agilent 1260; a detector: RID-G1362A shows a difference detector; a chromatographic column: carbomix Ca-Np, sepax technologies, Inc.; detecting the temperature of the cell: room temperature; separating column temperature: 80 ℃; mobile phase: ultrapure water; flow rate: 0.7 mL/min; sample injector: G1329A/B autosampler; sample introduction volume: 10 μ L. Observing the growth characteristics of the recombinant engineering strains, and detecting and analyzing fermentation substrates and products by using high performance liquid chromatography.
Example 6: recycling of erythritol crystallization mother liquor by recombinant strain
The host strain and the recombinant strain are respectively inoculated into 2.5mL of liquid culture medium (0.3 percent of yeast extract powder, 0.5 percent of peptone and 5 percent of glucose), and shake-cultured for 24 hours at 28 ℃ to obtain seed liquid. Transferring the seed solution into an erythritol mother solution fermentation medium (20% erythritol crystallization mother solution, 0.5% yeast extract powder and 0.5% triammonium citrate) with the inoculation amount of 10% at 28 ℃, shaking and culturing at 280 r/min for 72 h to obtain a fermentation solution, diluting and filtering, and detecting the contents of sugar and sugar alcohol in the metabolite by an HPLC method (figure 4).
Sequence listing
<110> research institute of food fermentation in China, Ltd
<120> a gene sequence comprising a sugar alcohol and an ATP binding domain and a method for expression and functional verification thereof in yarrowia lipolytica
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1831
<212> DNA
<213> Zygoascus hellenicus
<400> 1
atgtcagatt caaacggccc tctttatctt gtatgtgttt gcgggactca cttaaggggc 60
ccttttggtg ttcttttttt tttttttagc taagaaaacg attttacatt ctactatagg 120
ctcaattact ataaggcttg tttcagcaac taacataatc agggactgga tttgtctacg 180
cagcagctca aaggtgtcgt tgtcgatgcc aatttgatga ctgttagcag ctccaaagtt 240
gagtttgatg tggatattcc ttcgtacaag accatcaaag gagtctatgc aaaagggaaa 300
gaaatcgtgg ctccagtagc catgtggcta gaagctctgg atctactcat gcaacgatta 360
tctgagactc ctgggatatt agagagactg gcagcagtat ctggagcttg ccagcaacat 420
gggagtgtgt ttttcaactc caatgctgag caagcgttga agaacatggg acacgcggag 480
agcttgcgtt cggctttgga agattctttt gcatgggaaa tgtcacccaa ttggcaggat 540
cattcgactg gtatggagtg ctccaagttt gaagatgcgg ttggtggtaa gcagaagctt 600
gctgatatca caggatcacg agctcattat cggttcacgg gaccgcagat tctcaagctc 660
aagactcaac agcccgaaaa atacgcacag acgaaaagga tatcactggt gagcagtttt 720
ctgacatctg ttctagccgg gaaaatcagc gatattgaaa tatcagatgc atgtggcatg 780
aatctgtgga atgttgaggg tcgacactgg gaaccgaggc tgatccaagt gattggtgca 840
gaagttgaaa acaaactcgg ctcagtcgaa accaaaggag gagagtttgc gggactgatc 900
agcagctatt tcaccaaaaa gtatggcgtt tctcatgagt gccaagtcaa tttctgtact 960
ggtgataatc ctgggactat tttggcttta ccgttgcaga tgaatgatgt gatggttagc 1020
cttggaacca gtaccactgc actgatcgta accgagaact atcggcccag tcctttgtac 1080
cacttattca gccacccaac tggaagggga tatatgggaa tgctttgtta ttgtaatgga 1140
gctctcgcca gagagaaggt tcgggatagc ttgctaacca taggcagcag tagtgtctca 1200
ggagattcgg cttgggatga ttttaatgag attgcgattt cgggggctcc tctaggagcc 1260
gatgacaaag tcaaagctcg cctaggtgta tacttcccct tgggagaaat tatccccgat 1320
gtggggagcc aaacccgacg gttcgtggta tggcctgatg attccctcga agaagtgaaa 1380
tctggtgatg atgtaggcga tcccgatagt agcaatttgt ggggaaaaga gcaggatgtg 1440
gtgtgtattt tggaaagtca ggctctgagt atccgagaga gacttgagcc aatgttaaca 1500
acggccgaca aatgcccatc aaggatattt ttcgtcggcg gagggtccaa gaaccgtgca 1560
atttgtcaag taatgtccag ggtgctttca ccagccaacg gtgcttatcg gctcgagtta 1620
agcgatgcct gtgccatggg agctgctcac aaggctgcat gggccgatgt agctgatacc 1680
atcagctgga gctgatacca tcagctggga agcatttatt gatagcaagt ggaatatggc 1740
aaatgttcag gcggtgccgc agctagccgc agcttgtgac tatggagaaa ttgtgccgat 1800
atttgagcag atggagtctc ggcttgtata a 1831
<210> 2
<211> 603
<212> PRT
<213> Zygoascus hellenicus
<400> 2
Met Ser Ala Ser Ala Gly Pro Leu Thr Leu Val Cys Val Cys Gly Thr
1 5 10 15
His Leu Ala Gly Pro Pro Gly Val Leu Pro Pro Pro Pro Ser Gly Ala
20 25 30
Ala Pro Thr Pro Thr Thr Ala Leu Ala Thr Thr Leu Ala Cys Pro Ser
35 40 45
Ala His Ala Gly Gly Leu Ala Leu Ser Thr Gly Gly Leu Leu Gly Val
50 55 60
Val Val Ala Ala Ala Leu Met Thr Val Ser Ser Ser Leu Val Gly Pro
65 70 75 80
Ala Val Ala Ile Pro Ser Thr Leu Thr Ile Leu Gly Val Thr Ala Leu
85 90 95
Gly Leu Gly Ile Val Ala Pro Val Ala Met Thr Leu Gly Ala Leu Ala
100 105 110
Leu Leu Met Gly Ala Leu Ser Gly Thr Pro Gly Ile Leu Gly Ala Leu
115 120 125
Ala Ala Val Ser Gly Ala Cys Gly Gly His Gly Ser Val Pro Pro Ala
130 135 140
Ser Ala Ala Gly Gly Ala Leu Leu Ala Met Gly His Ala Gly Ser Leu
145 150 155 160
Ala Ser Ala Leu Gly Ala Ser Pro Ala Thr Gly Met Ser Pro Ala Thr
165 170 175
Gly Ala His Ser Thr Gly Met Gly Cys Ser Leu Pro Gly Ala Ala Val
180 185 190
Gly Gly Leu Gly Leu Leu Ala Ala Ile Thr Gly Ser Ala Ala His Thr
195 200 205
Ala Pro Thr Gly Pro Gly Ile Leu Leu Leu Leu Thr Gly Gly Pro Gly
210 215 220
Leu Thr Ala Gly Thr Leu Ala Ile Ser Leu Val Ser Ser Pro Leu Thr
225 230 235 240
Ser Val Leu Ala Gly Leu Ile Ser Ala Ile Gly Ile Ser Ala Ala Cys
245 250 255
Gly Met Ala Leu Thr Ala Val Gly Gly Ala His Thr Gly Pro Ala Leu
260 265 270
Ile Gly Val Ile Gly Ala Gly Val Gly Ala Leu Leu Gly Ser Val Gly
275 280 285
Thr Leu Gly Gly Gly Pro Ala Gly Leu Ile Ser Ser Thr Pro Thr Leu
290 295 300
Leu Thr Gly Val Ser His Gly Cys Gly Val Ala Pro Cys Thr Gly Ala
305 310 315 320
Ala Pro Gly Thr Ile Leu Ala Leu Pro Leu Gly Met Ala Ala Val Met
325 330 335
Val Ser Leu Gly Thr Ser Thr Thr Ala Leu Ile Val Thr Gly Ala Thr
340 345 350
Ala Pro Ser Pro Leu Thr His Leu Pro Ser His Pro Thr Gly Ala Gly
355 360 365
Thr Met Gly Met Leu Cys Thr Cys Ala Gly Ala Leu Ala Ala Gly Leu
370 375 380
Val Ala Ala Ser Leu Leu Thr Ile Gly Ser Ser Ser Val Ser Gly Ala
385 390 395 400
Ser Ala Thr Ala Ala Pro Ala Gly Ile Ala Ile Ser Gly Ala Pro Leu
405 410 415
Gly Ala Ala Ala Leu Val Leu Ala Ala Leu Gly Val Thr Pro Pro Leu
420 425 430
Gly Gly Ile Ile Pro Ala Val Gly Ser Gly Thr Ala Ala Pro Val Val
435 440 445
Thr Pro Ala Ala Ser Leu Gly Gly Val Leu Ser Gly Ala Ala Val Gly
450 455 460
Ala Pro Ala Ser Ser Ala Leu Thr Gly Leu Gly Gly Ala Val Val Cys
465 470 475 480
Ile Leu Gly Ser Gly Ala Leu Ser Ile Ala Gly Ala Leu Gly Pro Met
485 490 495
Leu Thr Thr Ala Ala Leu Cys Pro Ser Ala Ile Pro Pro Val Gly Gly
500 505 510
Gly Ser Leu Ala Ala Ala Ile Cys Gly Val Met Ser Ala Val Leu Ser
515 520 525
Pro Ala Ala Gly Ala Thr Ala Leu Gly Leu Ser Ala Ala Cys Ala Met
530 535 540
Gly Ala Ala His Leu Ala Ala Thr Ala Ala Val Ala Ala Thr Ile Ser
545 550 555 560
Thr Ser Thr His Gly Leu Gly Ser Ile Thr Gly Val Gly Thr Gly Leu
565 570 575
Cys Ser Gly Gly Ala Ala Ala Ser Ala Ser Leu Leu Thr Ala Ala Cys
580 585 590
Ala Ala Ile Ala Ala Gly Val Ser Ala Cys Ile
595 600

Claims (5)

1. A gene sequence comprising a sugar alcohol and an ATP-binding domain, the sequence having:
[0001] (1) a nucleotide sequence shown as SEQ ID NO. 1; or
(2) The nucleotide sequence shown in SEQ ID NO.1 is a sequence which is obtained by replacing, adding or deleting one or more nucleotides and encoding the same functional gene;
(3) a sequence which has homology of more than 75 percent with the sequence shown in SEQ ID NO.1 and encodes the same functional gene.
2. The gene sequence comprising a sugar alcohol and an ATP-binding domain according to claim 1, wherein the amino acid sequence of the expressed protein is as shown in SEQ ID No. 2.
3. Biological material comprising the gene sequence of claim 1, including recombinant vectors and recombinant strains;
in the recombinant vector, the vector can be a cloning vector and an expression vector;
in the recombinant strain, the strain can be bacteria and saccharomycetes.
4. The biomaterial according to claim 3, wherein the recombinant vector and the recombinant strain are constructed by a method comprising the steps of:
(1) constructing a recombinant cloning Vector pMD18-T Vector-spx containing the gene sequence;
(2) constructing a recombinant expression vector pINA1269-spx containing the gene sequence;
(3) transforming the recombinant expression vector into host yarrowia lipolytica;
(4) culturing, screening and identifying to obtain the recombinant strain.
5. The use of the nucleotide sequence according to claim 1 or the amino acid sequence according to claim 2 in erythritol fermentation production and erythritol waste liquor treatment processes.
CN202110247016.2A 2021-03-05 2021-03-05 Gene sequence containing sugar alcohol and ATP binding domain and expression and function verification method of gene sequence in yarrowia lipolytica Active CN113025634B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110247016.2A CN113025634B (en) 2021-03-05 2021-03-05 Gene sequence containing sugar alcohol and ATP binding domain and expression and function verification method of gene sequence in yarrowia lipolytica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110247016.2A CN113025634B (en) 2021-03-05 2021-03-05 Gene sequence containing sugar alcohol and ATP binding domain and expression and function verification method of gene sequence in yarrowia lipolytica

Publications (2)

Publication Number Publication Date
CN113025634A true CN113025634A (en) 2021-06-25
CN113025634B CN113025634B (en) 2022-04-08

Family

ID=76468203

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110247016.2A Active CN113025634B (en) 2021-03-05 2021-03-05 Gene sequence containing sugar alcohol and ATP binding domain and expression and function verification method of gene sequence in yarrowia lipolytica

Country Status (1)

Country Link
CN (1) CN113025634B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114456959A (en) * 2022-01-26 2022-05-10 山东星光首创生物科技有限公司 Hyperosmotic-resistant yarrowia lipolytica strain, breeding method and application

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101654677A (en) * 2009-09-17 2010-02-24 南京工业大学 Gene for highly expressing nuclease P1 and its application
CN109929883A (en) * 2019-04-02 2019-06-25 烟台华康荣赞生物科技有限公司 Recombination yeast, construction method and its preparing the application in tyrosol and derivative

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101654677A (en) * 2009-09-17 2010-02-24 南京工业大学 Gene for highly expressing nuclease P1 and its application
CN109929883A (en) * 2019-04-02 2019-06-25 烟台华康荣赞生物科技有限公司 Recombination yeast, construction method and its preparing the application in tyrosol and derivative
CN111139194A (en) * 2019-04-02 2020-05-12 烟台华康荣赞生物科技有限公司 Recombinant yeast, construction method and application thereof in preparation of tyrosol and derivative

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114456959A (en) * 2022-01-26 2022-05-10 山东星光首创生物科技有限公司 Hyperosmotic-resistant yarrowia lipolytica strain, breeding method and application

Also Published As

Publication number Publication date
CN113025634B (en) 2022-04-08

Similar Documents

Publication Publication Date Title
CN111712570B (en) Engineering strain for producing psicose and derivatives thereof, construction method and application thereof
US20170152538A1 (en) Biosynthesis of Oligosaccharides
CN111394292B (en) Multi-way composite neuraminic acid-producing bacillus subtilis and application thereof
US20220298536A1 (en) Improved oligosaccharide production in yeast
CN114874964A (en) Construction method and application of recombinant escherichia coli for high yield of 2&#39; -fucosyllactose
CN113025634B (en) Gene sequence containing sugar alcohol and ATP binding domain and expression and function verification method of gene sequence in yarrowia lipolytica
CN112662637A (en) Formate dehydrogenase mutant and preparation method and application thereof
CN111394410B (en) High-catalytic-activity neuraminic acid synthase and application thereof
CN113151337A (en) Method for expressing trehalose synthase by using EF-Tu promoter in corynebacterium glutamicum and application
CN110305855B (en) Gastrodia elata GeCPR gene and application thereof
CN104789586A (en) Escherichia coli genome integration vector, genetically engineered bacterium and application of genetically engineered bacterium to xylitol production
CN118103513A (en) Engineering bacterium for efficiently expressing D-psicose 3-epimerase and application
US8748152B1 (en) Prevotella ruminicola xylose isomerase and co-expression with xylulokinase in yeast for xylose fermentation
CN112266923B (en) Bacillus subtilis for expressing adenomethionine synthase and application thereof
CN113684191A (en) Pear head mould steroid 11 beta-hydroxylase CYP5311B2 mutant construction and application thereof
CN111826372A (en) Engineering strain for producing butanol by using xylose and construction method and application thereof
CN114752572B (en) Formate dehydrogenase mutant and application thereof
KR102253701B1 (en) Hybrid type glycolysis pathway
US20240060056A1 (en) Modified beta-1,3-n-acetylglucosaminyltransferase polypeptides
KR102613937B1 (en) Yeast strain in which all genes involved in galactose utilization are deleted and method for producing recombinant protein using the same
CN114875087B (en) Method for synthesizing 5-hydroxy beta-indolylalanine by taking beta-indolylalanine as substrate and application thereof
CN114058610B (en) High-activity sucrose isomerase and application thereof
CN113403315B (en) Gene expression cassette for improving thallus growth and generating biological enzyme potential
CN116622534A (en) Engineering strain for high yield of 2&#39; -fucosyllactose, construction method and application thereof
CN115322976A (en) Glucose quinic acid shikimic acid family PQQ-dependent membrane-bound dehydrogenase and coding gene and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant